Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutamic acid is a non-essential amino acid, meaning humans can synthesize it de novo.[2][7][9] It consists of an α-amino group, an α-carboxyl group, and a distinctive side chain terminating in a carboxylic acid, giving it acidic properties at physiological pH.[1][5][7] In proteins and metabolic pathways, it fulfills crucial roles as a metabolic intermediate and as the most abundant excitatory neurotransmitter in the brain (in the form of glutamate), mediating synaptic transmission essential to cognition, memory, and learning.[4][6][8] It is also important in nitrogen disposal (via the urea cycle), as a precursor to other amino acids, and in the regulation of cellular redox state via glutathione production. Although central to neurobiology, energy metabolism, and cellular function, glutamic acid itself is not a typical therapeutic "target"—therapies usually target glutamate receptors, transporters, or enzymes that act on or regulate glutamate[3][4][6][7][8].
Not applicable for glutamic acid itself; clinically, drugs may modulate glutamate receptors or transport, not the amino acid directly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamic acid (Glu (or E)).